其它产品项目整合

项目整合的本质是一项集合成方法学、反应工程学与过程分析技术于一体的系统工程。其核心逻辑可以概括为以下几点：源头优选：利用如N-硝胺化学等底层方法学突破，从分子层面颠覆传统高成本、高污染路线。过程强化：依托连续流技术，攻克有机金属试剂应用、光化学反应放大等“不可能”任务，实现高危工艺的本质安全。系统集成：整合“反应-淬灭-分离”全流程，利用微流控与在线分析技术，消除批次间的差异，实现药品制造的连续化与智能化。当前，中间体工艺研发正在经历从“经验驱动”向“数据驱动”的转变。AI辅助路线设计、自动化高通量筛选与连续制造平台的结合，将使得“分子结构与最优工艺路径”之间的映射关系逐渐清晰。未来的竞争优势，将属于那些能够将底层化学创新与先进工程技术进行无缝整合的研发体系。
备注: 根据相关法律法规, 本站点不显示有法律约束管制的产品, 如有遗漏, 请自行鉴别,或提交我们及时更新撤除.
如有产品相关项目调研推广服务, 请致函联系我们

客户展示

其它产品项目整合

Luteinizing Hormone CAS Registry Number: 9002-67-9 叶黄体化激素

Additional Names: LH; ICSH; interstitial cell stimulating hormone
Literature References: Gonadotropic hormone secreted by the anterior pituitary under the regulation of LH-RH, q.v. Together with follicle-stimulating hormone, q.v., is critical to the growth and maturity of ovarian follicles. Stimulates androgen production by ovarian theca cells that is converted to estrogen by granulosa cells. Induces ovalution and the development of the corpus luteum. In males, stimulates production of testosterone by Leydig cells of the testes. Structure is a heterodimer of non-covalently linked a and b subunits; analogous with FSH, TSH and chorionic gonadotropin, q.q.v. Isoln from sheep pituitaries: C. H. Li et al., Endocrinology 27, 803 (1940); eidem, Science 92, 355 (1940); eidem, J. Am. Chem. Soc. 64, 367 (1942). Isoln from pig pituitaries: T. Shedlovsky et al., Science 92, 178 (1940); B. F. Chow et al., Endocrinology 30, 650 (1942). Complete amino acid sequence of ovine LH subunits: H. Papkoff et al., J. Am. Chem. Soc. 93, 1531 (1971); W.-K. Liu et al., J. Biol. Chem. 247, 4351, 4365 (1972); of human LH subunits: H. T. Keutmann et al., Endocr. Res. Commun. 5, 57 (1978); eidem, Biochem. Biophys. Res. Commun. 90, 842 (1979). Reviews of structural studies: D. N. Ward et al., Recent Prog. Horm. Res. 29, 533-561 (1973); H. Papkoff et al., ibid. 563-590. Review of physiological roles: M. Filicori, Fertil. Steril. 71, 405-414 (1999); C. V. Rao, ibid. 76, 1097-1100 (2001); of clinical experience in ovulation induction: M. Filicori, G. E. Cognigni, J. Clin. Endocrinol. Metab. 86, 1437-1441 (2001); Z. Shoham, Fertil. Steril. 77, 1170-1177 (2002).

FM1-43 CAS Registry Number: 149838-22-2 N-(3-三乙基铵丙基)-4-(4-(二丁基氨基)苯乙烯基)吡啶二溴盐

CAS Name: 4-[2-[4-(Dibutylamino)phenyl]ethenyl]-1-[3-(triethylammonio)propyl]pyridinium dibromide
Additional Names: Neurodye GH1-43
Trademarks: SynaptoGreen (Biotium)
Percent Composition:...
Literature References: Green fluorescent styryl dye that binds to but is not translocated through biological membranes. Prepn and optical activity of p-aminostyrylpyridium probes: L. M. Loew et al., Biochemistry 17, 4065 (1978); A. Grinvald et al., Biophys. J. 39, 301 (1982). Optical analysis of synaptic vesicle recycling: W. J. Betz, G. S. Bewick, Science 255, 200 (1992); W. J. Betz et al., J. Neurosci. 12, 363 (1992); eidem, Curr. Opin. Neurobiol. 6, 365 (1996). Interaction with lipid membranes: U. Schote, J. Seelig, Biochim. Biophys. Acta 1415, 135 (1998); with background quenching: A. R. Kay et al., Neuron 24, 809 (1999); J. L. Pyle et al., ibid. 803. Use in membrane recycling study: T. J. Diefenbach et al., J. Neurosci. 19, 9436 (1999). Review of use and mechanism of action: M. A. Cousin, P. J. Robinson, J. Neurochem. 73, 2227-2239 (1999).

Ertapenem CAS Registry Number: 153832-46-3 厄他培南

CAS Name: [4R,5S,6S]-3-[[(3S,5S)-5-[[(3-Carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Additional Name...
Literature References: Group 1 carbapenem antibiotic. Prepn: M. J. Betts et al., WO 9315078; eidem, US 5478820 (1993, 1995 both to Zeneca). Large-scale synthesis: J. M. Williams et al., J. Org. Chem. 70, 7479 (2005). Pharmacokinetics in primates: J. G. Sundelof et al., Antimicrob. Agents Chemother. 41, 1743 (1997). In vivo efficacy and pharmacokinetics: C. J. Gill et al., ibid. 42, 1996 (1998). In vitro efficacy and b-lactamase stability: J. Kohler et al., ibid. 43, 1170 (1999). HPLC determn in plasma and urine: D. G. Musson et al., J. Chromatogr. B 720, 99 (1998); of residual crystallization solvents: T. K. Natishan, Y. Wu, ibid. A 800, 275 (1998). Series of articles on pharmacology and clinical experience in complicated community-acquired infections: J. Antimicrob. Chemother. 53, Suppl. S2, ii1-ii86 (2004).

Fibroblast Growth Factor CAS Registry Number: 62031-54-3 重组人碱性成纤维细胞生长因子OsrhbFGF

Additional Names: FGF
Literature References: Growth stimulatory factor originally isolated from bovine brain and pituitary and found to stimulate DNA synthesis in cultured fibroblast cells. Isoln: D. Gospodarowicz, Nature 249, 123 (1974). Mitogenic effect on cultured cell lines and induction of amphibian limb regeneration in vivo: D. Gospodarowicz et al., Adv. Metab. Disord. 8, 301 (1975). Two closely related forms have been identified, known as basic (bFGF) and acidic (aFGF) fibroblast growth factors, having a total amino acid sequence homology of 55%. Both induce the proliferation and differentiation of a wide variety of cell types, including corneal and vascular endothelial cells, myoblasts, chondrocytes, osteoblasts and glial cells. FGF has neurotrophic and angiogenic activity and may play an important role in the wound healing process. Purification of bFGF from pituitary: D. Gospodarowicz, J. Biol. Chem. 250, 2515 (1975); from brain: D. Gospodarowicz et al., ibid. 253, 3736 (1978). Identification of aFGF from bovine brain: K. A. Thomas et al., ibid. 255, 5517 (1980). Comparison of fibroblast growth factors: S. K. Lemmon et al., J. Cell Biol. 95, 162 (1982). Purification and characterization of aFGF: K. A. Thomas et al., Proc. Natl. Acad. Sci. USA 81, 357 (1984). Identity of bFGF from brain and pituitary: D. Gospodarowicz et al., ibid. 6963. Amino acid sequence of bFGF: F. Esch et al., ibid. 82, 6507 (1985); of aFGF: G. Gimenez-Gallego et al., Science 230, 1385 (1985); F. Esch et al., Biochem. Biophys. Res. Commun. 133, 554 (1985). Possible identity of aFGF with endothelial cell growth factor (ECGF) and eye-derived growth factor-II (EDGF-II): A. B. Schreiber et al., J. Cell Biol. 101, 1623 (1985); of bFGF with macrophage-derived growth factor (MDGF): A. Baird et al., Biochem. Biophys. Res. Commun. 126, 358 (1985); of FGFs with retina-derived endothelial cell growth factors: A. Baird et al., Biochemistry 24, 7855 (1985). Cloning of cDNA for bovine bFGF: J. A. Abraham et al., Science 233, 545 (1986); for human bFGF: T. Kurokawa et al., FEBS Lett. 213, 189 (1987); M. Iwane et al., Biochem. Biophys. Res. Commun. 146, 470 (1987). Expression of a chemically synthesized gene for bioactive bovine aFGF: D. L. Linemeyer et al., Biotechnology 5, 960 (1987). Receptor binding study: G. Neufeld, D. Gospodarowicz: J. Biol. Chem. 261, 5631 (1986). FGF-like factors have been isolated from several human tumor cell lines: R. R. Lobb et al., Biochem. Biophys. Res. Commun. 139, 861 (1986); M. Klagsbrun et al., Proc. Natl. Acad. Sci. USA 83, 2448 (1986); D. Moscatelli et al., J. Cell. Physiol. 129, 273 (1986). FGF has also been shown to be structurally homologous to the protein products of several oncogenes: C. Dickson, G. Peters, Nature 326, 833 (1987); M. Taira et al., Proc. Natl. Acad. Sci. USA 84, 2980 (1987); P. Delli Bovi et al., Cell 50, 729 (1987). Review of tissue distribution and bioactivity of bFGF: A. Baird et al., Recent Prog. Horm. Res. 42, 143-205 (1986). Review of structural characterization and biological functions: D. Gospodarowicz et al., Endocr. Rev. 8, 95-114 (1987). Potential role in the control of pituitary and gonad development: D. Gospodarowicz, N. Ferrara, J. Steroid Biochem. 32, 183-191 (1989). Reviews: K. A. Thomas, G. Gimenez-Gallego, Trends Biochem. Sci. 11, 81-84 (1986); D. Gospodarowicz et al., Mol. Cell. Endocrinol. 46, 187-204 (1986); K. A. Thomas, FASEB J. 1, 434-440 (1987).

Gigantine CAS Registry Number: 32829-58-6 (1S)-6,7-二甲氧基-1,2-二甲基-3,4-二氢-1H-异喹啉-5-醇

CAS Name: 1,2,3,4-Tetrahydro-6,7-dimethoxy-1,2-dimethyl-5-isoquinolinol
Percent Composition: C 65.80%, H 8.07%, N 5.90%, O 20.23%
Literature References: Hallucinogen from the cactus Carnegia gigantea Engelm. Cactaceae: Hodgkins et al., Tetrahedron Lett. 1967, 1321. Structure: Kapadia et al., Chem. Commun. 1970, 856. Synthesis: eidem, Chem. Ind. (London) 1970, 1593; Choudhury ibid. 1971, 578.

Halofuginone CAS Registry Number: 55837-20-2 氢溴酸常山酮

CAS Name: rel-7-Bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone
Additional Names: (±)-trans-7-bromo-6-chloro-3-[3-(3-hydroxy-2-piperidyl)acetonyl]-4(...
Literature References: Halogenated deriv of febrifugine, q.v. Prepn: E. Waletzky et al., US 3320124 (1967 to Am. Cyanamid). In vivo and in vitro activity: J. G. Ryley et al., Parasitology 70, 203 (1975). Toxicity to fresh water organisms: Bull. Environ. Contam. Toxicol. 15, 720 (1976). HPLC determn in chicken feed: A. Anderson et al., J. Chromatogr. 168, 471 (1979); in chicken serum: R. C. Beier et al., J. Liq. Chromatogr. 17, 2961 (1994). Evaluation as coccidiostat: P. E. Waibel et al., Poult. Sci. 66, 1629 (1987). Inhibition of collagen synthesis and effect on skin tearing: I. Granot et al., ibid. 70, 1559 (1991).

Guaiacol Valerate CAS Registry Number: 531-39-5 (2-甲氧基苯基)戊酸酯

Percent Composition: C 69.21%, H 7.74%, O 23.05%
Literature References: Has antibacterial properties: Kellner, Kober, Arzneim.-Forsch. 5, 224 (1955).

Cysteic Acid CAS Registry Number: 13100-82-8 磺基丙氨酸

CAS Name: 3-Sulfoalanine
Additional Names: a-amino-b-sulfopropionic acid
Percent Composition: C 21.30%, H 4.17%, N 8.28%, O 47.29%, S 18.96%
Literature References: Has been isolated from human hair oxidized with permanganate: Lissizin, Z. Physiol. Chem. 173, 309 (1928). Occurs normally in the outer part of the sheep's fleece, where the wool is exposed to light and weather: Martin, Synge, Adv. Protein Chem. 2, 3 (1945). Prepd from cystine or cysteine by oxidation with bromine in water: Friedmann, Beitr. Chem. Physiol. Pathol. 3, 25, 38; Gortner, Hoffman, J. Biol. Chem. 72, 435 (1927).

a -Estradiol CAS Registry Number: 57-91-0 17α-雌二醇

CAS Name: (17a)-Estra-1,3,5(10)-triene-3,17-diol
Additional Names: 1,3,5-estratriene-3,17a-diol; 3,17-dihydroxyestratriene
Percent Composition: C 79.37%, H 8.88%, O 11.75%
Literature References: Has been isolated from pregnancy urine of mares. Prepn from b-estradiol by inversion of the hydroxyl group at C-17 after tosylation: Allais, Hoffmann, US 2835681 (1958).

Dextran Sulfate Sodium CAS Registry Number: 9011-18-1 硫酸葡聚糖钠盐

Additional Names: Dextran sulfuric acid ester sodium salt
Trademarks: Asuro (Nippon Kayaku); Colyonal (Mochida); Dexulate; Dextrarine; MDS
Literature References: Heparin-like polysaccharide containing approx. 17% S with up to three sulfate groups per glucose molecule. Mol wt ranges from 4,000-500,000 Da; variations in mol wt are associated with differences in biological activity. Prepn, properties and anticoagulant activity: A. Grönwall et al., Upsala Laekarefoeren. Foerh. 50, 397 (1945); C. R. Ricketts, Biochem. J. 51, 129 (1952). Evaluation of toxicity as a function of mol wt: K. W. Walton, Br. J. Pharmacol. 9, 1 (1954); of carcinogenicity: I. Hirono et al., Cancer Lett. 18, 29 (1983). Use in serum HDL cholesterol determn: P. R. Finley et al., Clin. Chem. 24, 931 (1978); G. R. Warnick et al., ibid. 28, 1379 (1982). Antiscrapie effect: B. Ehlers, H. Diringer, J. Gen. Virol. 65, 1325 (1984); R. H. Kimberlin, C. A. Walker, Antimicrob. Agents Chemother. 30, 409 (1986). Anti-HIV-1 activity in vitro: H. Mitsuya et al., Science 240, 646 (1988); M. Baba et al., Proc. Natl. Acad. Sci. USA 85, 6132 (1988).